Related Experiment Video
Updated: Apr 20, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma
Zhengming Su1, Liangchao Ni2, Wenshui Yu1
1Department of Urology, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Abstract:
MicroRNAs (miRNAs) are an important class of small, non‑coding RNA molecules that regulate gene expression at the transcriptional or post‑transcriptional level. They are involved in apoptosis, proliferation and migration and are known to have an important role in many types of cancer. Aberrant expression of miRNA‑451a (miR‑451a) has previously been reported in tumors, however its role in renal cell carcinoma (RCC) is currently unknown. The aim of the present study was to investigate the role of miR‑451a in RCC. The expression of miR‑451a was analyzed in 50 paired RCC and normal tissues by quantitative polymerase chain reaction. Furthermore, the effects of miR‑451a on cell migration, proliferation and apoptosis were evaluated, using migration scratch, MTT and flow cytometric assays. The present study demonstrated that miR‑451a was upregulated in RCC, as compared with paired normal tissues (P<0.05). Downregulation of miR‑451a using a synthesized inhibitor, significantly suppressed cell migration and proliferation, and induced apoptosis of renal cancer cells in vitro, as compared with a negative control (P<0.05). In the present study, it was determined that miR‑451a may have an important role as a tumor enhancer in RCC. These results imply that miR‑451a may be a promising therapeutic target for the treatment of RCC.
Insights
MicroRNA-451a (miR-451a) is elevated in renal cell carcinoma (RCC) and promotes tumor growth. Inhibiting miR-451a suppressed cancer cell migration and proliferation while inducing apoptosis, suggesting it as a potential therapeutic target for RCC.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression involved in cancer development.
- Aberrant miRNA expression is implicated in various cancers, but miR-451a's role in renal cell carcinoma (RCC) remains unclear.
Purpose of the Study:
- To investigate the expression and function of miR-451a in renal cell carcinoma (RCC).
- To determine the potential of miR-451a as a therapeutic target for RCC.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) to analyze miR-451a expression in 50 paired RCC and normal tissues.
- In vitro assays including migration scratch, MTT, and flow cytometry to assess the effects of miR-451a inhibition on renal cancer cells.
Main Results:
- miR-451a was significantly upregulated in RCC tissues compared to normal tissues (P<0.05).
- Inhibition of miR-451a suppressed renal cancer cell migration and proliferation.
- Downregulation of miR-451a induced apoptosis in renal cancer cells in vitro (P<0.05).
Conclusions:
- miR-451a acts as a tumor enhancer in renal cell carcinoma.
- miR-451a represents a promising therapeutic target for the treatment of RCC.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

